Investment House LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $327K | Hold |
525
| – | – | 0.01% | 196 |
|
|
2026
Q1 | $406K | Sell |
525
-15
| -3% | -$11.5K | 0.02% | 179 |
|
|
2025
Q4 | $417K | Sell |
540
-117
| -18% | -$79.5K | 0.02% | 178 |
|
|
2025
Q3 | $369K | Hold |
657
| – | – | 0.02% | 192 |
|
|
2025
Q2 | $345K | Sell |
657
-32
| -5% | -$17.9K | 0.02% | 191 |
|
|
2025
Q1 | $437K | Hold |
689
| – | – | 0.02% | 182 |
|
|
2024
Q4 | $491K | Hold |
689
| – | – | 0.03% | 164 |
|
|
2024
Q3 | $724K | Sell |
689
-10
| -1% | -$11.1K | 0.04% | 156 |
|
|
2024
Q2 | $735K | Hold |
699
| – | – | 0.04% | 144 |
|
|
2024
Q1 | $673K | Hold |
699
| – | – | 0.04% | 149 |
|
|
2023
Q4 | $614K | Sell |
699
-16
| -2% | -$13.2K | 0.04% | 142 |
|
|
2023
Q3 | $588K | Sell |
715
-450
| -39% | -$354K | 0.05% | 134 |
|
|
2023
Q2 | $837K | Hold |
1,165
| – | – | 0.06% | 126 |
|
|
2023
Q1 | $957K | Hold |
1,165
| – | – | 0.08% | 116 |
|
|
2022
Q4 | $841K | Hold |
1,165
| – | – | 0.08% | 105 |
|
|
2022
Q3 | $803K | Sell |
1,165
-30
| -3% | -$18.9K | 0.08% | 113 |
|
|
2022
Q2 | $706K | Hold |
1,195
| – | – | 0.06% | 115 |
|
|
2022
Q1 | $835K | Hold |
1,195
| – | – | 0.06% | 115 |
|
|
2021
Q4 | $755K | Hold |
1,195
| – | – | 0.05% | 125 |
|
|
2021
Q3 | $723K | Hold |
1,195
| – | – | 0.05% | 128 |
|
|
2021
Q2 | $667K | Hold |
1,195
| – | – | 0.05% | 137 |
|
|
2021
Q1 | $565K | Hold |
1,195
| – | – | 0.04% | 135 |
|
|
2020
Q4 | $577K | Hold |
1,195
| – | – | 0.04% | 147 |
|
|
2020
Q3 | $669K | Hold |
1,195
| – | – | 0.05% | 133 |
|
|
2020
Q2 | $745K | Sell |
1,195
-15
| -1% | -$8.51K | 0.07% | 121 |
|
|
2020
Q1 | $591K | Buy |
1,210
+30
| +3% | +$12.4K | 0.07% | 121 |
|
|
2019
Q4 | $443K | Sell |
1,180
-50
| -4% | -$16.8K | 0.04% | 161 |
|
|
2019
Q3 | $341K | Sell |
1,230
-723
| -37% | -$214K | 0.03% | 159 |
|
|
2019
Q2 | $611K | Sell |
1,953
-60
| -3% | -$20K | 0.06% | 130 |
|
|
2019
Q1 | $827K | Buy |
2,013
+180
| +10% | +$74.1K | 0.09% | 123 |
|
|
2018
Q4 | $685K | Sell |
1,833
-105
| -5% | -$38.4K | 0.09% | 116 |
|
|
2018
Q3 | $783K | Sell |
1,938
-5
| -0.3% | -$1.9K | 0.08% | 118 |
|
|
2018
Q2 | $670K | Sell |
1,943
-455
| -19% | -$142K | 0.08% | 127 |
|
|
2018
Q1 | $826K | Buy |
+2,398
| New | +$834K | 0.1% | 115 |
|
Other funds holding REGN
Investment House LLC's REGN Position: Q2 2026 in Review
Investment House LLC held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 525 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #196.
Investment House LLC first reported a position in REGN in Q1 2018 and has held it in 34 quarters since. The position peaked at $957K in Q1 2023. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Investment House LLC held 525 shares of Regeneron Pharmaceuticals worth $327K as of Q2 2026.
- Investment House LLC left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Investment House LLC's portfolio in Q2 2026, its #196 holding.
- Investment House LLC first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 34 quarters since.
- Investment House LLC's Regeneron Pharmaceuticals position peaked at $957K in Q1 2023.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Investment House LLC's 13F filing for Q2 2026, filed 21 Jul 2026.